Organization for Human Brain Mapping 2003 Annual Meeting
Seeing Alzheimer’s: Advances in Brain Mapping Bring Goal a Step Closer Organization for Human Brain Mapping 2003 Annual Meeting
6401 RESULTS
Sort By:
Seeing Alzheimer’s: Advances in Brain Mapping Bring Goal a Step Closer Organization for Human Brain Mapping 2003 Annual Meeting
I-han Chou reports from Brain Mapping Conference in New York City.
Synapses—those specialized junctions that facilitate transmission of action potentials between neurons—are composed of a myriad of highly sophisticated proteins. Some, like neurexins, have yet to be fully characterized...
In this month's Nature Cell Biology, Frank Lezoualc'h and colleagues at the University of South Paris report that serotonin, or 5-hydroxy tryptamine (5HT), mediates sAPPα release through a cyclic AMP (cAMP) signaling pathway independent of protein kinase A (PKA)...
Alzforum scientific advisor Vincent Marchesi is currently director of the Boyer Center of Molecular Medicine at Yale University School of Medicine.
In the 24 June PNAS Early Edition, researchers report that a biologically ancient defense mechanism for ridding the central nervous system (CNS) of invading pathogens also damages neurons...
Soon after the World Health Organization bestowed its approval on the protein 14-3-3 as an important diagnostic marker for sporadic Creutzfeldt-Jakob disease (sCJD), reports began to come in that its sensitivity and specificity might not be all that was advertised...
Papers in press in the Journal of Biological Chemistry and PNAS explore the relationship between Alzheimer's disease (AD) and nicotine...
The U.S. Food and Drug Administration has given approval for the drug Stalevo—a cocktail of levodopa (L-dopa), carbidopa, and entacapone—to be marketed in the United States for the treatment of Parkinson's disease...
The blood-brain barrier (BBB) is cropping up with increasing frequency in discussions of Alzheimer's disease therapy. It is an ever-present concern for researchers hoping to introduce therapies...
The not-for-profit Amyotrophic Lateral Sclerosis-Therapy Development Foundation (ALS-TDF), based in Newton, Massachusetts, has entered into a collaboration with University of Chicago stem cell researcher Kimonobu Sugaya...
Two in-press papers in the Journal of Biological Chemistry reveal the crystal structure of DJ-1, a protein of unknown function that was recently implicated in the etiology of familial Parkinson's disease...
In last week's PNAS online, researchers reported that murine embryonic stem cells exposed to pyrrolpyrimidines differentiate into neurons. This result raises hope that the fate of stem cells in vivo may one day be controlled by the use of small molecules...
News Pointer: RNAi Horizon Symposium Highlights Nature/Aventis Horizon Symposium: Understanding the RNAissance
Enjoy an online summary of a <a href="http://www.nature.com/horizon/rna/index.html">Nature/Aventis Horizon Symposium</a> held last month in Maine...
No filters selected